Charleston, SC -- (SBWIRE) -- 08/16/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: ARCAM AB ORD (OTCMKTS:AMAVF), MusclePharm Corp (OTCMKTS:MSLP), Affymax, Inc. (OTCMKTS:AFFY), WebXU Inc (OTCMKTS:WBXU)
ARCAM AB ORD (OTCMKTS:AMAVF) remained a bear for the day as it reported the loss of -6.46% and closed at $89.79 after gaining total volume of 44,433 shares. Its introductory price for the day was $94.90. So far, the company’s stock is up +94.03% in the three months period. In the last 6 months of trade it reported a gain of +149.43%.
Arcam AB provides additive manufacturing solutions for the production of metal components. The company offers Arcam Q10, an electron beam melting (EBM) machine for the industrial production of orthopedic implants; and Arcam A2, a solution for additive manufacturing of metal parts from a range of different materials in the aerospace industry.
Why Should Investors Buy AMAVF After the Recent Fall? Just Go Here and Find Out
MusclePharm Corp (OTCMKTS:MSLP) reported the gain of +7.18% and closed at $ 10.45 with the total traded volume of 111,192 shares. The stock's opening price was $ 10.00. The company has a total market capitalization of $ 105.83 million.
The 52-week price range of the stock remained $3.40 - $13.10, while during last trade its minimum price was $9.80 and it gained its highest price of $11.20. Company's last 5 days shows a down turn with a decline of -9.91%. MusclePharm Corporation develops, manufactures, and markets sports nutrition products in the United States and internationally.
What was the Moving Force behind MSLP On Bullish Run? Read This Research Report
Affymax, Inc. (OTCMKTS:AFFY) ended its day with the declining stream with the plunge of -1.25% and closed at the price of $1.58 after opening at $1.58. Stock traded during its last trading session with the total volume of 503,010 shares, as compared to its average volume of 1.14 million shares.
During the previous session, the company’s minimum price was $1.58, while it touched its highest price for the day at $1.61. AFFY’s beta value stands at 1.46 points. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Has AFFY Found The Bottom And Ready To Gain Momentum? Find Out Here
WebXU Inc (OTCMKTS:WBXU) reported the drop of -19.00%, to close at $0.0405, with the overall traded volume of 2.92 million shares.
So far, in the past three months, the stock is down -68.85%. The 52-week range for the stock is $0.04 and $1.01 and during the previous trading session the stock touched its highest price at $0.06. Its introductory price for the day was $0.06. Webxu, Inc., a performance media company, develops, owns, and operates a network of branded consumer Websites. It acquires and integrates consumer-oriented businesses in the customer acquisition and e-commerce categories.
Will WBXU Get Buyers Even After The Recent Rally? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)